24 July 2026
24 July 2026
The study aims to assess the safety, efficacy and device performance of the Venus-PowerX in severe aortic stenosis patients.
The Phase I trial aims to determine maximum tolerated dose, evaluate pharmacokinetics, and gather preliminary efficacy data.
Lu AH69593 is currently being studied in a Phase Ib clinical trial focused on patients with narcolepsy.
AFTX-201 is an investigational gene therapy delivered through a single intravenous infusion.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
